Position
Chief Scientific Officer
Company
Estrella Immunopharma
CaliforniaBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Estrella Immunopharma has appointed Cynthia Pussinen as Chief Executive Officer effective October 25, 2026. Ms. Pussinen succeeds Cheng Liu, Ph.D., who will take on the role of Chief Scientific Officer.
Quick answer
Estrella Immunopharma Appoints Cynthia Pussinen as Chief Executive Officer (October 26, 2026). Estrella Immunopharma is based in California, United States.
- What did Estrella Immunopharma announce on October 26, 2026?
- Estrella Immunopharma has appointed Cynthia Pussinen as Chief Executive Officer effective October 25, 2026. Ms. Pussinen succeeds Cheng Liu, Ph.D., who will take on the role of Chief Scientific Officer.
- What does Estrella Immunopharma do?
- Estrella Immunopharma is a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancers and autoimmune diseases.
- Where is Estrella Immunopharma based?
- Estrella Immunopharma is based in California, United States.
- Which similar companies made leadership changes around the same time?
- Cantargia AB (October 26, 2026), Acadia Pharmaceuticals (October 23, 2026), Celea Therapeutics (October 29, 2026) and Retension Pharmaceuticals (October 23, 2026) also announced leadership changes within 45 days of Estrella Immunopharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cantargia AB Appoints Monic Stuart as Chief Medical Officer (October 26, 2026)
- Acadia Pharmaceuticals Announces Departure of Elizabeth H.Z. Thompson, Ph.D. (October 23, 2026)
- Celea Therapeutics Appoints Paul Audhya as Chief Medical Officer (October 29, 2026)
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
- Peter Anastasiou Appointed as President and CEO of Harmony Biosciences (October 30, 2026)
Who to call at Estrella Immunopharma, and when
A new leader at Estrella Immunopharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Estrella Immunopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Estrella Immunopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Estrella Immunopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Estrella Immunopharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Estrella Immunopharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.